cyc 202 has been researched along with d 4476 in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (d 4476) | Trials (d 4476) | Recent Studies (post-2010) (d 4476) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 18 | 0 | 13 |
| Protein | Taxonomy | cyc 202 (IC50) | d 4476 (IC50) |
|---|---|---|---|
| TGF-beta receptor type-1 | Homo sapiens (human) | 0.5 | |
| Casein kinase II subunit alpha | Schizosaccharomyces pombe 972h- | 0.2 | |
| Casein kinase I isoform alpha | Homo sapiens (human) | 0.3 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.2678 | |
| Casein kinase I isoform epsilon | Homo sapiens (human) | 0.319 | |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | 0.3 | |
| Casein kinase I isoform delta | Rattus norvegicus (Norway rat) | 0.3267 | |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | 9.1 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 4.977 | |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
3 other study(ies) available for cyc 202 and d 4476
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |